PharmGKB summary: dopamine receptor D2.
作者信息
Mi Huaiyu, Thomas Paul D, Ring Huijun Z, Jiang Ruhong, Sangkuhl Katrin, Klein Teri E, Altman Russ B
机构信息
Evolutionary Systems Biology, Artificial Intelligence Center, SRI International, Menlo Park, California, USA.
出版信息
Pharmacogenet Genomics. 2011 Jun;21(6):350-6. doi: 10.1097/FPC.0b013e32833ee605.
Abstract
摘要
相似文献
1
PharmGKB summary: dopamine receptor D2.
Pharmacogenet Genomics. 2011 Jun;21(6):350-6. doi: 10.1097/FPC.0b013e32833ee605.
2
Dopamine D2 receptor promoter polymorphism: no association with schizophrenia.
Psychiatry Res. 1999 Feb 22;85(2):215-9. doi: 10.1016/s0165-1781(98)00125-5.
3
Lack of association between two dopamine D2 receptor gene polymorphisms and schizophrenia.
Psychiatr Genet. 2011 Aug;21(4):214-5. doi: 10.1097/YPG.0b013e328341e020.
4
Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia.
Schizophr Res. 1999 Nov 9;40(1):31-6. doi: 10.1016/s0920-9964(99)00033-x.
5
Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients.
Schizophr Res. 2001 Apr 15;49(1-2):223-5. doi: 10.1016/s0920-9964(99)00147-4.
6
-141C insertion/deletion polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in Chinese Han population: Evidence from an ethnic group-specific meta-analysis.
Asia Pac Psychiatry. 2016 Sep;8(3):189-98. doi: 10.1111/appy.12206. Epub 2015 Sep 7.
7
[Linkage sib-pair analysis of dopamine receptor D2 gene Taq1A and Taq1B polymorphism and schizophrenia].
Zh Nevrol Psikhiatr Im S S Korsakova. 2002;102(4):43-4.
8
Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia.
Mol Psychiatry. 2003 Nov;8(11):911-5. doi: 10.1038/sj.mp.4001321.
9
Schizophrenia: normal sequence in the dopamine D2 receptor region that couples to G-proteins. DNA polymorphisms in D2.
Neuropsychopharmacology. 1993 Feb;8(2):137-42. doi: 10.1038/npp.1993.15.
10
Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients.
Prog Neuropsychopharmacol Biol Psychiatry. 2000 Oct;24(7):1105-13. doi: 10.1016/s0278-5846(00)00132-9.
引用本文的文献
1
Impact of the Polymorphisms on the Effectiveness of the Training Program.
Int J Environ Res Public Health. 2022 Apr 19;19(9):4942. doi: 10.3390/ijerph19094942.
2
History of the dopamine hypothesis of antipsychotic action.
World J Psychiatry. 2021 Jul 19;11(7):355-364. doi: 10.5498/wjp.v11.i7.355.
3
The pharmacogenomics of severe traumatic brain injury.
Pharmacogenomics. 2017 Oct;18(15):1413-1425. doi: 10.2217/pgs-2017-0073. Epub 2017 Oct 4.
4
Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long-acting injection: a case report.
BMC Psychiatry. 2017 Jul 3;17(1):238. doi: 10.1186/s12888-017-1396-x.
5
Posttraumatic Brain Injury Cognitive Performance Is Moderated by Variation Within ANKK1 and DRD2 Genes.
J Head Trauma Rehabil. 2015 Nov-Dec;30(6):E54-66. doi: 10.1097/HTR.0000000000000118.
6
Databases in the area of pharmacogenetics.
Hum Mutat. 2011 May;32(5):526-31. doi: 10.1002/humu.21454. Epub 2011 Apr 5.
本文引用的文献
1
D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.
Am J Psychiatry. 2010 Jul;167(7):763-72. doi: 10.1176/appi.ajp.2009.09040598. Epub 2010 Mar 1.
2
Ligand functional selectivity advances our understanding of drug mechanisms and drug discovery.
Neuropsychopharmacology. 2010 Jan;35(1):345-6. doi: 10.1038/npp.2009.117.
3
Management of schizophrenia with obesity, metabolic, and endocrinological disorders.
Psychiatr Clin North Am. 2009 Dec;32(4):775-94. doi: 10.1016/j.psc.2009.08.003.
4
Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas.
Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):43-53. doi: 10.1517/17425250903352501.
5
Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?
Curr Pharm Des. 2010;16(5):488-501. doi: 10.2174/138161210790361461.
6
The D2 dopamine receptor gene variant C957T affects human fear conditioning and aversive priming.
Genes Brain Behav. 2010 Feb;9(1):103-9. doi: 10.1111/j.1601-183X.2009.00543.x. Epub 2009 Oct 7.
7
The ANKK1 gene associated with addictions is expressed in astroglial cells and upregulated by apomorphine.
Biol Psychiatry. 2010 Jan 1;67(1):3-11. doi: 10.1016/j.biopsych.2009.08.012.
8
Novel therapeutic strategies in Parkinson's disease.
Eur J Clin Pharmacol. 2010 Feb;66(2):119-25. doi: 10.1007/s00228-009-0742-4. Epub 2009 Oct 16.
9
Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.
Curr Pharm Des. 2009;15(22):2550-9. doi: 10.2174/138161209788957528.
10
Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease.
Eur J Clin Pharmacol. 2009 Dec;65(12):1245-51. doi: 10.1007/s00228-009-0708-6.
Zotero 插件